▶ 전체 게시글 텍스트
Another batch of company write-ups from Substack authors from within the last week.
Not my work - sourced from Giles Capital's weekly compilation: [https://gilescapital.substack.com](https://gilescapital.substack.com)
# Americas
**Rijnberk InvestInsights** on [**Shopify**](https://rijnberkinvestinsights.substack.com/p/shopify-a-deep-dive-into-the-toll) (🇨🇦 SHOP TSX - CAD$198bn)
Shopify commands 29% of US e-commerce at 63x P/E. The toll across Payments, Capital, and expanding B2B either compounds faster than the multiple compresses, or it does not.
**D Invests** on [**Tractor Supply**](https://dinvests.substack.com/p/tractor-supply-a-yield-worth-harvesting) (🇺🇸 TSCO US - US$23.5bn)
Rural lifestyle retailer at 14.7x P/E, dominant in markets where no national competitor exists. Management buybacks underway as insider penetration at 43% of US rural households suggests structural demand.
**Archive Invest** on [**Toast**](https://archiveinvest.substack.com/p/down-47-from-its-peak-this-business) (🇺🇸 TOST US - US$15.1bn)
Restaurant software covering 28% of US food service. Down 47% from its peak, yet with $1.8bn net cash, zero sell ratings among covering analysts, and EBITDA guidance improving.
**DeepValue Capital** on [**KBR**](https://deepvaluecapitalbykyler.substack.com/p/kbr-inc-kbr-notes) (🇺🇸 KBR US - US$3.5bn)
Government services and engineering at $3.5bn market cap. HomeSafe contract termination put the author on the sideline; the $2.2bn net debt is the reason the bar to re-enter stays high.
**Value Don't Lie** on [**MasterBrand**](https://www.valuedontlie.com/p/quick-value-316-masterbrand-inc-mbc) (🇺🇸 MBC US - US$1.8bn)
Largest US cabinet maker after the all-stock merger, at 30%+ market share. Trades at 7.7x trough EBITDA; a housing recovery and $90M in merger synergies are the thesis.
**Unfair Advantage** on [**Natural Grocers**](https://unfairadvantagecapital.substack.com/p/natural-grocers-by-vitamin-cottage) (🇺🇸 NGVC US - US$659M)
22 straight years of positive comp sales; Isely family owns 43%. In-house nutritionists advising supplements are the loyalty moat competitors cannot copy. P/E 13.5x with mid-teen growth targets.
# Europe, Middle East & Africa
**Demystified Value** on [**Prada**](https://demystifiedvalue.substack.com/p/prada-spa-hk-1913-a-portfolio-of) (🇮🇹 1913 HK - US$12.5bn)
Luxury at 9x EV/EBIT while peers trade 16-25x. Miu Miu growing 60%+, 80% Prada family control. The discount only makes sense if the brand is impaired; the evidence says otherwise.
**310 Value** on [**eDreams ODIGEO**](https://310value.substack.com/p/edreams-disproving-the-bears-and) (🇪🇸 EDRE MC - €490M) TOP PICK
All the attention is on the -64% drawdown. The underlying business has 7.9M Prime subscribers, EBITDA up 74% over nine months, and management buying stock at P/E 5.1x.
# Asia-Pacific
**G.W. Field Notes** on [**ASX Limited**](https://sgwfieldnotes.substack.com/p/asx-limited-could-be-hidden-value) (🇦🇺 ASX ASX - US$6bn)
Australia's dominant exchange monopoly at 8x sales versus 11x historically, 4.2% yield. The CHESS failure is the reason for the discount; the moat across listing, trading, and clearing has not changed.
**KonichiValue** on [**Koei Tecmo Holdings**](https://www.konichivalue.com/p/koei-tecmo-holdings-tyo-3635-the) (🇯🇵 3635 TYO - US$3.4bn)
Dynasty Warriors maker at 11.5x P/E; the Erikawa family's investment portfolio outearned the gaming division last year. Clean balance sheet: ¥115bn net cash against a $3.4bn market cap. Market prices it as a mid-tier studio.
**Value Guinea** on [**Da Ren Tang and Beijing Tong Ren Tang National Medicine**](https://jingshu.substack.com/p/franchise-or-management-team) (🇨🇳 600329 SS - US$4.2bn / 🇨🇳 3613 HK - US$913M)
Da Ren Tang ($3.8bn, P/E 14.6, 43% net margin) and Tong Ren Tang ($913M) run the same TCM franchise. Equity reform and ROE 28% tell one story; SOE governance tells the other.
**stf research** on [**Sakai Chemical Industry**](https://stfbutnou.substack.com/p/sakai-chemical-the-upstream-play) (🇯🇵 4078 TYO - ¥89bn)
World's largest barium sulfate supplier to AI cooling systems, 30%+ market share, guidance raised. Stock up 90% since publication; the thesis is intact but the re-rating is already priced.
**Archetype Capital** on [**Sakai Chemical Industry and Nippon Chemical Industrial**](https://www.archetype-research.com/p/sakai-chemical-and-nippon-chemical) (🇯🇵 4078 TYO - ¥89bn / 🇯🇵 4092 TYO - ¥48bn)
Follow-on pairing the market leader with the #3 barium sulfate supplier. Both up 90-130% since initial coverage; whether the oligopoly structure holds is now the question.
**Value Zoomer** on [**Focus Point Holdings**](https://valuezoomer.substack.com/p/focusing-on-focus-point) (🇲🇾 FOCUSP KLSE - US$83M) TOP PICK
Malaysia's dominant optical chain, with a government ban on online contact lens sales eliminating the price competition that held back margins. 51% founder control, 9x P/E, 90 stores.